NBIX financial statements

The full income statement, balance sheet, and cash-flow statement for Neurocrine Biosciences Inc. (NBIX), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 101.0M2024-09 101.2M2024-12 99.7M2025-03 99.0M2025-06 99.2M2025-09 99.7M2025-12 100.4M2026-03 100.5M2026-06 101.6M+0.7% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeYoYQoQFiguresAs-reported fiscal years.

Line item	FY2025	FY2024	FY2023	FY2022	FY2021
Income Statement	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
Revenue	2.86B YoY+21.4%	2.36B YoY+24.8%	1.89B YoY+26.8%	1.49B YoY+31.3%	1.13B YoY+8.4%
Cost of revenue	52.1M YoY+53.2%	34.0M YoY-14.4%	39.7M YoY+71.1%	23.2M YoY+62.2%	14.3M YoY+41.6%
	—	—	—	—	1.03B YoY+16.8%
Research & development	1.02B YoY+38.9%	731M YoY+29.4%	565M YoY+21.8%	464M YoY+41.4%	328M YoY+19.3%
Selling, general & administrative	1.16B YoY+14.8%	1.01B YoY+13.5%	888M YoY+17.9%	753M YoY+29.0%	583M YoY+34.6%
Amortization of intangibles	4.10M YoY+13.9%	3.60M YoY+2.9%	3.50M YoY+600.0%	500K	0.00
Operating income	619M YoY+8.5%	571M YoY+127.4%	251M YoY+0.8%	249M YoY+142.9%	103M YoY-37.1%
Interest expense	—	—	4.60M YoY-35.2%	7.10M YoY-72.5%	25.8M YoY-21.3%
Other non-operating income	86.3M YoY+202.1%	-84.5M YoY-204.1%	81.2M YoY+331.3%	-35.1M YoY-3090.9%	-1.10M YoY+98.0%
Gain (loss) on equity securities	-4.00M YoY+89.2%	-37.1M YoY-230.6%	28.4M YoY-7.8%	30.8M YoY+47.4%	20.9M YoY+218.1%
Pre-tax income	705M YoY+45.1%	486M YoY+46.3%	332M YoY+55.3%	214M YoY+110.9%	101M YoY-5.0%
Income tax	227M YoY+56.7%	145M YoY+75.6%	82.4M YoY+38.7%	59.4M YoY+403.4%	11.8M YoY+103.9%
	479M YoY+40.2%	341M YoY+36.7%	250M YoY+61.6%	155M YoY+72.4%	89.6M YoY-78.0%
Net income to common	479M YoY+40.2%	341M YoY+36.7%	250M YoY+61.6%	155M YoY+72.4%	89.6M YoY-78.0%
	$4.67 YoY+41.9%	$3.29 YoY+33.2%	$2.47 YoY+58.3%	$1.56 YoY+69.6%	$0.92 YoY-77.9%
EPS (basic)	$4.81 YoY+41.5%	$3.40 YoY+32.8%	$2.56 YoY+59.0%	$1.61 YoY+69.5%	$0.95 YoY-78.3%
	99.5M YoY-0.9%	100M YoY+2.8%	97.7M YoY+2.0%	95.8M YoY+1.3%	94.6M YoY+1.6%
	103M YoY-1.2%	104M YoY+2.7%	101M YoY+2.1%	98.9M YoY+1.0%	97.9M YoY+0.1%
Balance Sheet	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
	2.52B YoY+46.3%	1.72B YoY+7.3%	1.61B YoY+10.6%	1.45B YoY+49.4%	973M YoY-4.3%
Cash & equivalents	713M YoY+206.0%	233M YoY-7.2%	251M YoY-4.5%	263M YoY-22.9%	341M YoY+82.1%
Short-term investments	—	—	—	—	371M YoY-39.6%
Accounts receivable	687M YoY+43.4%	479M YoY+9.1%	439M YoY+25.5%	350M YoY+88.7%	186M YoY+18.1%
Inventory	69.0M YoY+20.2%	57.4M YoY+49.9%	38.3M YoY+9.1%	35.1M YoY+15.1%	30.5M YoY+8.9%
Prepaid expenses	171M YoY+252.0%	48.5M	—	—	—
Other current assets	116M YoY+82.1%	63.6M YoY-35.0%	97.8M YoY+23.6%	79.1M YoY+73.8%	45.5M YoY+51.2%
	4.63B YoY+24.5%	3.72B YoY+14.4%	3.25B YoY+37.3%	2.37B YoY+14.3%	2.07B YoY+19.5%
Property, plant & equipment	89.8M YoY+8.7%	82.6M YoY+16.7%	70.8M YoY+20.8%	58.6M YoY+0.0%	58.6M YoY+31.4%
Operating lease right-of-use	455M YoY-10.6%	509M YoY+84.2%	277M YoY+217.8%	87.0M YoY-10.5%	97.2M YoY+17.4%
Goodwill	6.10M YoY+7.0%	5.70M YoY-1.7%	5.80M YoY+7.4%	5.40M	0.00
Intangible assets	4.70M YoY-87.1%	36.5M YoY+2.8%	35.5M YoY-4.6%	37.2M	0.00
Long-term investments	—	—	—	299M YoY-46.6%	561M YoY+146.9%
Deferred tax assets	320M YoY-34.1%	486M YoY+33.9%	363M YoY+18.5%	306M YoY-2.9%	315M YoY-1.3%
Other non-current assets	48.7M YoY-6.3%	52.0M YoY+4.8%	49.6M YoY+98.4%	25.0M YoY+468.2%	4.40M YoY-31.3%
	743M YoY+46.4%	508M YoY-22.5%	655M YoY+21.8%	538M YoY+118.8%	246M YoY+31.8%
Accrued liabilities	674M YoY+46.1%	462M YoY+2.9%	449M YoY+29.1%	348M YoY+53.9%	226M YoY+33.8%
Current lease liability	56.0M YoY+37.9%	40.6M YoY+26.9%	32.0M YoY+83.9%	17.4M YoY+5.5%	16.5M YoY+60.2%
Other current liabilities	69.1M YoY+49.9%	46.1M YoY+28.4%	35.9M YoY+73.4%	20.7M YoY+3.5%	20.0M YoY+12.4%
	1.38B YoY+22.1%	1.13B YoY+10.8%	1.02B YoY+54.2%	661M YoY-5.4%	699M YoY+14.8%
Non-current lease liability	415M YoY-8.7%	455M YoY+76.2%	258M YoY+176.3%	93.5M YoY-11.2%	105M YoY+11.5%
Operating lease liability (total)	471M YoY-4.9%	496M YoY+70.8%	290M YoY+161.8%	111M YoY-8.9%	122M YoY+16.3%
Deferred tax liabilities	0.00	—	—	—	—
Other non-current liabilities	220M YoY+32.2%	166M YoY+56.3%	106M YoY+257.9%	29.7M YoY+141.5%	12.3M YoY+26.8%
	3.25B YoY+25.6%	2.59B YoY+16.0%	2.23B YoY+30.7%	1.71B YoY+24.3%	1.37B YoY+22.0%
Preferred stock	0.00	0.00	0.00	0.00	0.00
Common stock	100K YoY+0.0%	100K YoY+0.0%	100K YoY+0.0%	100K YoY+0.0%	100K YoY+0.0%
Additional paid-in capital	2.79B YoY+9.3%	2.55B YoY+7.2%	2.38B YoY+12.2%	2.12B YoY+5.5%	2.01B YoY+8.7%
Retained earnings	448M YoY+1433.2%	29.2M YoY+118.6%	-157M YoY+61.4%	-407M YoY+36.0%	-636M YoY+12.4%
Accumulated other comprehensive income	13.1M YoY+125.9%	5.80M YoY-17.1%	7.00M YoY+188.6%	-7.90M YoY-364.7%	-1.70M YoY-194.4%
Total liabilities & equity	4.63B YoY+24.5%	3.72B YoY+14.4%	3.25B YoY+37.3%	2.37B YoY+14.3%	2.07B YoY+19.5%
	100M YoY+0.7%	99.4M YoY+0.7%	98.7M YoY+2.3%	96.5M YoY+1.7%	94.9M YoY+1.5%
	100M YoY+0.7%	99.4M YoY+0.7%	98.7M YoY+2.3%	96.5M YoY+1.7%	94.9M YoY+1.5%
	100M YoY+0.7%	99.7M YoY+0.2%	99.5M YoY+3.0%	96.6M YoY+1.4%	95.2M YoY+1.4%
Cash Flow	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
	783M YoY+31.5%	595M YoY+52.7%	390M YoY+14.9%	339M YoY+32.3%	257M YoY+12.3%
Depreciation & amortization	30.1M YoY+11.1%	27.1M YoY+27.2%	21.3M YoY+36.5%	15.6M YoY+43.1%	10.9M YoY+26.7%
Intangible amortization	4.10M YoY+13.9%	3.60M YoY+2.9%	3.50M YoY+600.0%	500K	0.00
Share-based compensation	218M YoY+11.5%	196M YoY+0.6%	194M YoY+12.2%	173M YoY+29.0%	134M YoY+34.2%
Deferred income taxes	164M YoY+233.5%	-123M YoY-102.6%	-60.7M YoY-375.9%	22.0M YoY+300.0%	5.50M YoY+101.8%
Change in receivables	211M YoY+428.9%	39.8M YoY-55.4%	89.3M YoY-44.9%	162M YoY+471.1%	28.4M YoY-6.9%
Change in inventory	15.3M YoY-19.9%	19.1M YoY+453.7%	-5.40M YoY-307.7%	2.60M YoY+4.0%	2.50M YoY-76.6%
Other operating activities	700K YoY+600.0%	100K YoY-85.7%	700K YoY-56.3%	1.60M YoY+153.3%	-3.00M YoY-181.1%
	-264M YoY-108.5%	-127M YoY+72.9%	-467M YoY-163.7%	-177M YoY-36.0%	-130M YoY-3275.6%
Capital expenditure	34.0M YoY-11.0%	38.2M YoY+35.0%	28.3M YoY+71.5%	16.5M YoY-29.5%	23.4M YoY+114.7%
Free cash flow	749M YoY+34.4%	557M YoY+54.1%	362M YoY+12.0%	323M YoY+38.5%	233M YoY+7.1%
Acquisitions	0.00	0.00	0.00 YoY-100.0%	42.7M	0.00
	-38.3M YoY+92.1%	-487M YoY-845.3%	65.3M YoY+127.9%	-234M YoY-955.1%	27.4M YoY+117.4%
Long-term debt issued	0.00	0.00	0.00	0.00	0.00
Long-term debt repaid	0.00	0.00	0.00	0.00	0.00
Common stock issued	129M YoY+6.0%	122M YoY+87.0%	65.3M YoY+46.1%	44.7M YoY+62.5%	27.5M YoY-5.5%
Common stock repurchased	168M YoY-44.1%	300M	0.00	0.00	0.00
Dividends paid	0.00	0.00	0.00	0.00	0.00
FX effect on cash	0.00	0.00 YoY-100.0%	300K YoY+123.1%	-1.30M	0.00
Net change in cash	480M YoY+2751.9%	-18.1M YoY-56.0%	-11.6M YoY+84.2%	-73.3M YoY-147.7%	154M YoY+105.5%
Interest paid	0.00 YoY-100.0%	1.60M YoY-57.9%	3.80M YoY-42.4%	6.60M YoY-23.3%	8.60M YoY-25.9%
Income taxes paid	81.4M YoY-62.6%	218M YoY+322.3%	51.5M YoY+257.6%	14.4M YoY+182.4%	5.10M YoY-66.7%
Valuation Ratios	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
Market cap	14.2B YoY+4.6%	13.6B YoY+5.1%	12.9B YoY+12.7%	11.5B YoY+41.6%	8.11B YoY-9.9%
P/E	29.7× YoY-25.4%	39.9× YoY-41.2%	67.8× YoY-65.6%	197.3× YoY+117.9%	90.5× YoY+309.5%
P/S	5.0× YoY-13.9%	5.8× YoY-20.4%	7.3× YoY-12.2%	8.3× YoY+15.5%	7.2× YoY-16.9%
P/B	4.4× YoY-16.7%	5.3× YoY-18.7%	6.5× YoY-13.0%	7.4× YoY+25.9%	5.9× YoY-26.2%
P/FCF	19.0× YoY-22.2%	24.4× YoY-27.4%	33.7× YoY-48.1%	64.9× YoY+86.4%	34.8× YoY-15.9%
	3.4% YoY+34.1%	2.5% YoY+70.0%	1.5% YoY+191.1%	0.51% YoY-54.1%	1.1% YoY-75.6%
	5.3% YoY+28.5%	4.1% YoY+37.8%	3.0% YoY+92.8%	1.5% YoY-46.4%	2.9% YoY+18.9%
Source filing	10-K	10-K	10-K	10-K	10-K

About this data

Source: NBIX's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all NBIX filings on SEC EDGAR → Not investment advice.